David A Axelrod1, Krista L Lentine2, Huiling Xiao2, Thomas Bubolz3, David Goodman3, Richard Freeman4, Janet E Tuttle-Newhall2, Mark A Schnitzler2. 1. Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH; The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH. Electronic address: david.a.axelrod@hitchcock.org. 2. St. Louis University Center for Outcomes Research, St. Louis University, St. Louis, MO. 3. The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH. 4. Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH.
Abstract
BACKGROUND: The provision of effective surgical care for end-stage renal disease (ESRD) requires efficient evaluation and transplantation. Prior assessments of transplant access have focused primarily on waitlisted patients rather than the overall populations served by "accountable" providers of transplant services. METHODS: Novel transplant referral regions (TRRs) were defined using United Network for Organ Sharing registry data for 301,092 kidney transplant listings to assign zip codes to "accountable" transplant programs. Subsequently, risk-adjusted observed to expected (O:E) rates of listing and transplant procedures were calculated for each TRR. Finally, the impact of variation in TRR listing and transplant rates on mortality was assessed for ESRD patients <60 years old diagnosed between 2000 and 2008. RESULTS: In total, 113 TRRs were defined, 51% of which included >1 transplant center. The likelihood of being evaluated and listed for transplant varied significantly between TRRs (risk-adjusted O:E, 0.58-1.95). Variation was greater for the overall transplant rate (0.62-2.19), living donor transplantation (0.36-3.08), and donation after cardiac death transplant (0-15.4) than for standard criteria donors (0.64-2.86). Mortality was decreased for ESRD patients living in TRRs in the highest tertile of listings (hazard ratio, 0.89; P < .0001) and transplantation (0.90; P < .0001). CONCLUSION: Residence in a TRR with care delivery systems that increase access to transplant services is associated with significant, risk-adjusted decreases in ESRD-related mortality. Transplant centers should continue to focus on improving access to care within the communities they serve.
BACKGROUND: The provision of effective surgical care for end-stage renal disease (ESRD) requires efficient evaluation and transplantation. Prior assessments of transplant access have focused primarily on waitlisted patients rather than the overall populations served by "accountable" providers of transplant services. METHODS: Novel transplant referral regions (TRRs) were defined using United Network for Organ Sharing registry data for 301,092 kidney transplant listings to assign zip codes to "accountable" transplant programs. Subsequently, risk-adjusted observed to expected (O:E) rates of listing and transplant procedures were calculated for each TRR. Finally, the impact of variation in TRR listing and transplant rates on mortality was assessed for ESRDpatients <60 years old diagnosed between 2000 and 2008. RESULTS: In total, 113 TRRs were defined, 51% of which included >1 transplant center. The likelihood of being evaluated and listed for transplant varied significantly between TRRs (risk-adjusted O:E, 0.58-1.95). Variation was greater for the overall transplant rate (0.62-2.19), living donor transplantation (0.36-3.08), and donation after cardiac death transplant (0-15.4) than for standard criteria donors (0.64-2.86). Mortality was decreased for ESRDpatients living in TRRs in the highest tertile of listings (hazard ratio, 0.89; P < .0001) and transplantation (0.90; P < .0001). CONCLUSION: Residence in a TRR with care delivery systems that increase access to transplant services is associated with significant, risk-adjusted decreases in ESRD-related mortality. Transplant centers should continue to focus on improving access to care within the communities they serve.
Authors: Michael A Freeman; John R Pleis; Kellee R Bornemann; Emilee Croswell; Mary Amanda Dew; Chung-Chou H Chang; Galen E Switzer; Anthony Langone; Anuja Mittal-Henkle; Somnath Saha; Mohan Ramkumar; Jareen Adams Flohr; Christie P Thomas; Larissa Myaskovsky Journal: Transplantation Date: 2017-06 Impact factor: 4.939
Authors: Sarah E Van Pilsum Rasmussen; Alvin G Thomas; Jacqueline Garonzik-Wang; Macey L Henderson; Sarah S Stith; Dorry L Segev; Lauren Hersch Nicholas Journal: Transpl Int Date: 2018-06-10 Impact factor: 3.782
Authors: Peter P Reese; Justine Shults; Roy D Bloom; Adam Mussell; Meera N Harhay; Peter Abt; Matthew Levine; Kirsten L Johansen; Jason T Karlawish; Harold I Feldman Journal: Am J Kidney Dis Date: 2015-07-07 Impact factor: 8.860
Authors: Courtenay M Holscher; Satinderjit S Locham; Christine E Haugen; Sunjae Bae; Dorry L Segev; Mahmoud B Malas Journal: J Nephrol Date: 2019-01-02 Impact factor: 3.902
Authors: Sudeshna Paul; Laura C Plantinga; Stephen O Pastan; Jennifer C Gander; Sumit Mohan; Rachel E Patzer Journal: Clin J Am Soc Nephrol Date: 2018-01-25 Impact factor: 8.237
Authors: Xingyu Zhang; Taylor A Melanson; Laura C Plantinga; Mohua Basu; Stephen O Pastan; Sumit Mohan; David H Howard; Jason M Hockenberry; Michael D Garber; Rachel E Patzer Journal: Am J Transplant Date: 2018-04-18 Impact factor: 8.086
Authors: Vishnu S Potluri; Chirag R Parikh; Isaac E Hall; Joseph Ficek; Mona D Doshi; Isabel Butrymowicz; Francis L Weng; Bernd Schröppel; Heather Thiessen-Philbrook; Peter P Reese Journal: Clin J Am Soc Nephrol Date: 2015-12-14 Impact factor: 8.237
Authors: Mukoso N Ozieh; Kinfe G Bishu; Rebekah J Walker; Jennifer A Campbell; Leonard E Egede Journal: BMC Health Serv Res Date: 2016-10-18 Impact factor: 2.655